SEVELAMER CARBONATE
NEFRAL 800MG FC TABLET
800mg Film-Coated Tablet
Indication*
Hyperphosphataemia inn Chronic Kidney disease.
Directions for Use*
Adult: In patients on haemodialysis or peritoneal dialysis, or for those not requiring dialysis: As sevelamer carbonate or sevelamer hydrochloride: Initially, 800-1,600 mg tid. Dose should be initiated based on serum phosphorus level:>5.5-<7.5 mg/dL: 800 mg tid; >7.5 mg/dL: 1,600 mg tid. Adjust the dose gradually by 800 mg tid increment every 2-4 weeks until achieving the desired serum phosphorus levels. Treatment and dosing recommendations may vary among individual products and between countries (refer to specific product guidelines). Child: As sevelamer carbonate: >6 years BSA >0.75-<1.2 M2: 800 mg tid, titrate by 400 mg tid every 2-4 weeks as necessary; BSA >1.2 m2: 1,600 mg tid, titrate by 800 mg tid every 2-4 weeks as necessary. Treatment and dosing recommendations may vary among individual products and between countries (refer to specific product guidelines).
Administration*
Should be taken with food.
*written indications, directions, and administration are updated as of April 04, 2024 and may not be accurate with the actual product purchased. Please read the details in the packaging.
|
Your Price
Regular price ₱42.00 |
Member Price
Regular price |
Couldn't load pickup availability
